Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy
Sign Up to like & getrecommendations! Published in 2024 at "Theranostics"
DOI: 10.7150/thno.96946
Abstract: Rationale: Current treatments for ocular angiogenesis primarily focus on blocking the activity of vascular endothelial growth factor (VEGF), but unfavorable side effects and unsatisfactory efficacy remain issues. The identification of novel targets for anti-angiogenic treatment… read more here.
Keywords: 1599 ocular; tsrna 1599; ocular angiogenesis; tsrna ... See more keywords